Ftse Mib
32.908,05
0,74%
DAX
18.068,21
0,26%
S&P 500
5.473,23
0,77%
NASDAQ
17.857,02
0,95%
Bitcoin
65.471,42
-1,53%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE AbbVie Inc (ABBV) AbbVie Inc (ABBV) Notizie

AbbVie Inc

ABBV
169,68
1,09 (0,65%)
18 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/6/202422:08PRNUSAbbVie Recommends Shareholders Reject Tutanota's..
13/6/202413:59PRNUSAbbVie and FutureGen Announce License Agreement to Develop..
11/6/202414:00PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women..
06/6/202414:45PRNUSAbbVie Announces Positive Topline Results from Phase 2..
06/6/202414:30PRNUSSkinMedica® Celebrates 25 Years of Empowering Radiant Skin
06/6/202414:00PRNUSAbbVie Launches First-of-its-Kind Contest to Empower People..
05/6/202415:00PRNUSAbbVie Advances Oncology Pipeline With Start of Multiple..
04/6/202414:30PRNUSRINVOQ® (upadacitinib) Now Available for Pediatric Patients..
04/6/202414:05PRNUSRefer Your Friends to Allē, the Loyalty Rewards Program by..
03/6/202414:30PRNUSAbbVie to Present at the Goldman Sachs 45th Annual Global..
31/5/202422:05EDGAR2Form SD - Specialized disclosure report
31/5/202408:00PRNUSAbbVie Receives Positive CHMP Opinion for Risankizumab..
28/5/202414:00PRNUSAbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024..
23/5/202422:05PRNUSAbbVie Completes Acquisition of Landos Biopharma
17/5/202413:30PRNUSAbbVie Presents New Data Supporting Leading Gastroenterology..
13/5/202414:39PRNUSAbbVie and Gilgamesh Pharmaceuticals Announce Collaboration..
08/5/202423:00EDGAR2Form 8-K/A - Current report: [Amend]
08/5/202414:00PRNCAQULIPTA™ (atogepant) Now Approved by Health Canada for the..
08/5/202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202414:00PRNUSAbbVie to Present at the Bank of America Securities..
26/4/202413:47IHMARKETNEWSU.S. Futures Climb in Pre-Market Trading Amid Tech Gains and..
26/4/202413:35PRNUSAbbVie Reports First-Quarter 2024 Financial Results
25/4/202414:00PRNUSNew Data Show RINVOQ® (upadacitinib) Demonstrated..
23/4/202414:00PRNUSAllergan Aesthetics Invites Consumers to Be the Face of..
18/4/202414:31PRNUSPhase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed..
12/4/202413:30PRNUSAbbVie Announces Late-Breaking Data at AAN Supporting..
09/4/202414:00PRNUSSkinMedica® Empowers Clear Skin Confidence with a New,..
04/4/202414:00PRNUSAbbVie to Host First-Quarter 2024 Earnings Conference Call
03/4/202414:30PRNUSAllergan Aesthetics Announces the Return of CoolMonth with..
01/4/202413:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
26/3/202412:20IHMARKETNEWSSuper Micro Computer and Seagate Shares Surge on Analyst..
25/3/202416:00PRNUSAllergan Aesthetics Launches "Moving the Needle on Ethics"..
25/3/202413:31PRNUSAbbVie to Acquire Landos Biopharma, Further Strengthening..
25/3/202413:30GLOBEAbbVie to Acquire Landos Biopharma, Further Strengthening..
22/3/202420:02PRNUSU.S. Food and Drug Administration (FDA) Grants Full Approval..
21/3/202413:00PRNUSALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY,..
07/3/202414:00PRNUSAbbVie to Present at the Barclays 26th Annual Global..
06/3/202414:03PRNUSAbbVie and Allergan Aesthetics to Present New Data at 2024..
05/3/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:09PRNCADragonfly a reçu un paiement d'étape à la suite de la prise..
05/3/202414:00PRNUSJUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA..
05/3/202413:00PRNCADragonfly has Received Milestone Payment Following Dosing of..
02/3/202401:53EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 168,89 Min: 167,36 Max: 170,40
Chiusura: 168,59

La tua Cronologia

NYSE
ABBV
AbbVie
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network